|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||3.7500 - 3.9200|
|52 Week Range||1.0600 - 4.1700|
|Beta (3Y Monthly)||1.39|
|PE Ratio (TTM)||N/A|
|Earnings Date||Apr 30, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CEO Interviews with: HEXO, HOTH, MDCL, NEXCFNews & VIDEO from Investor Conferences: NEXCF, MDCL NEW YORK, Sept. 18, 2019 -- Wall Street Reporter, the trusted name in.
- Canaccord Genuity 2nd Annual U.S. Cannabis Symposium Conference on October 3, 2019 in Toronto, Canada - Alliance Global Partners Consumer Cannabis Conference on October 3, 2019 in New York City - Company ...
SmallCapVoice.com Inc. and Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company") today announced that Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies is featured in a new audio interview at SmallCapVoice.com. Williams into SmallCapVoice.com, Inc. to go over the exciting news for the Company, their roll-up strategy that would solidify the Company as one of the largest vertically integrated cannabis operators in North America, the operational goals for the company in 2019 and much more. Williams discussed at length the recent acquisitions made possible by the passage of House Bill 19-1090, which was signed into law by Colorado Gov. Jared Polis on May 29, 2019, thus opening up Colorado's cannabis industry to outside investors and enabling increased investment by venture capitalists and private equity firms.
Maybe the most aggressive company in the cannabis sector over the last month has been Medicine Man Tech (MDCL). The stock wasn’t even on the radar until the company made aggressive acquisitions in the last few months with deals on a daily basis in the last week. Investors should cautiously watch from the sidelines until the deals are integrated.Aggressive Deal MakingBack on September 6, Benzinga highlighted how Medicine Man Tech bought 9 companies this year. Well, the management team went on a ramped-up spree over the next week.The company has bought Canyon LLC, Strawberry Fields, an unnamed dispensary owner and Roots RX. Some of the deals are appealing with Canyon LLC offering premium edibles at a cost of only $5.1 million with a 2019 revenue target of $3.3 million.Other deals such as the unnamed dispensaries in Colorado don’t appear as attractive. The company is paying $50.1 million for four operating dispensaries and a fifth under construction as the cost of roughly $10.0 million per store. The stores are projected to have attractive 35% EBITDA margins and come after the company had reportedly bought 22 dispensaries in Colorado over a period of a week.The deal for Strawberry Fields adds another four stores plus manufacturing and cultivation facilities for $31 million. In total, the company with a listed market cap of only $140 million has purchased the following dispensaries to reach a total of 34: * Medicine Man – 4 * Purplebees – 4 * Starbuds – 5 * Colorado Harvest – 3 * Dispensary Group – 4 * Roots Rx – 6 * Strawberry Fields – 4Big Investor The passing of House Bill 19-1090 opened up the market for cannabis industry in Colorado to attract outside investors and capital, including publicly held companies. This new legislation allows for acquisitions to take place on or after November 1, 2019.The company has obtained large funding from Dye Capital to carry out this string of acquisitions. Dye Capital has invested $21 million via the purchase of 8 million shares. In addition, the investment firm has warrants to purchase up to 7.5 million warrants at prices of up to $3.50 per share.Mr. Dye was named Chairman of the Board and has extensive experience in rolling up a retailer via past investments in Albertsons. His position on the board provides confidence the investment is long term in nature.The biggest issue for small investors is that limited financial details have been provided. The company is now projecting annual revenues of $170 million with EBITDA margins in the 20% range but integrating so many different operations into one business is a daunting task.TakeawayThe key investor takeaway is that Medicine Man Tech is trading at the highs near $4 as the market likes the momentum and large investor. Small investors have limited ability to analyze all of the acquisitions or the ability of this company to integrate the operations into a single entity.The best option is to watch the stock from the sidelines until some of the hype is out of a stock that has rallied from $1 in December to $4 now.Visit TipRanks’ Trending Stocks page, and find out what companies Wall Street’s top analysts are looking at now.Disclosure: No position.
NEW YORK, Sept. 16, 2019 -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published published CEO Interviews, video presentations, and news.
DENVER, Sept. 16, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company") announced a culmination of its roll-up strategy today that would solidify the Company as one of the largest vertically integrated cannabis operators in North America upon closing of these pending acquisitions—and as a deeply experienced retailer and manufacturer of cannabis-infused products and concentrates driven by a leadership team that has unprecedented experience in regulated cannabis markets.
In the coming weeks Benzinga Cannabis' managing director Javier Hasse will be touring the Americas, speaking at four major cannabis conferences. DETROIT, Sept. 13, 2019 /PRNewswire/ -- Benzinga, a financial technology company centered on delivering actionable trading insights, is announcing its managing director for cannabis, Javier Hasse, will be touring the Americas and speaking at four major cannabis conferences in upcoming weeks. Below is a list of major speaking engagements.
DENVER, Sept. 13, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company"), announced today that the Company will present at the Fall Investor Summit being held on September 16-17, 2019, at the Essex House in New York City. Tigran Muradyan, Director of Investor Relations of Medicine Man Technologies, will deliver an overview of the Company, highlight the Company's numerous pending acquisitions, and discuss the Company's strategic goal of becoming a leading vertically integrated cannabis brand and operator. Additionally, Mr. Muradyan will serve as a guest speaker at noon EST on Monday, September 16, for the Cannabis Panel, which will focus on the evolution of the cannabis industry and key trends within the sector.
DENVER, Sept. 12, 2019 /PRNewswire/ -- MedPharm Holdings ("MedPharm"), reiterated today its formal policy prohibiting the use of suspected unsafe chemical additives to its entire line of cannabis products, most notably its concentrates that are used in vape products. Furthermore, Medicine Man Technologies (MDCL) ("Medicine Man Technologies" or the "Company") calls on the state of Colorado — and the other 49 states — to enact an industry-wide standard prohibiting certain excipients in vape products.
Medicine Man Technologies, Inc. (OTC: MDCL) said Thursday it has signed a binding term sheet to acquire Canyon LLC, a Colorado producer of premium-infused edibles. The purchase price is $5.13 million in cash and common stock that will be fixed in the long form agreement, according to Medicine Man. The amount payable in cash wouldn’t exceed $2.565 million, and the shares will have a value of $3.07 per share. "Canyon has been on our radar for several years given its strong following and high-quality manufacturing and extraction methods.
DENVER, Sept. 12, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company"), announced today that it has entered into a binding term sheet to acquire Canyon LLC ("Canyon"), a leading Colorado manufacturer of all-natural, discreet, and highly effective premium-infused edibles.
Anyone who closely follows the cannabis industry knows that it is experiencing unrivaled growth. The year is set to end with a 31.7% increase in annual legal cannabis sales, bolstered by new regulation, ...
Medicine Man Technologies will purchase Strawberry Fields for $31 million, consisting of $14 million in cash and $17 million in common stock, satisfied by the issuance of 5,704,698 shares of its common stock priced at $2.98 per share. The purchase price may be subject to adjustment, which will be detailed in the long form agreement entered into among the parties.
DENVER , Sept. 9, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company") announced today that it will be webcasting its presentation ...
Medicine Man Technologies, Inc. (OTC: MDCL) announced Monday it has signed a binding term sheet to purchase four additional dispensaries in Colorado. "These four dispensaries to be acquired culminate a tremendous run over the last week in which we announced the planned acquisitions of 22 dispensaries in Colorado," co-founder and CEO Andy Williams said in a statement.
DENVER, Sept. 9, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company"), announced today that it has entered into a binding term sheet to acquire four additional dispensaries in Colorado from a leading cannabis retailer. Under the terms of the transaction, Medicine Man Technologies will purchase the group of four dispensaries for $50,096,413, consisting of $25,048,206.50 in cash, the issuance of 4,202,720 shares of its common stock at a price of $2.98 per share, and a deferred cash payment of $12,524,103.25 to be made 12 months following the initial closing date. "These four dispensaries to be acquired culminate a tremendous run over the last week in which we announced the planned acquisitions of 22 dispensaries in Colorado," commented Andy Williams, Co-Founder and Chief Executive Officer of Medicine Man Technologies. "With an estimated 35% EBITDA margin, these retail stores are collectively expected to be some of the most profitable in our portfolio.
Earlier this week, Medicine Man Technologies Inc (OTC: MDCL ) announced its ninth acquisition since the passing of the HB19-1090, Publicly Licensed Marijuana Companies bill, in Colorado, in April. Over ...
DENVER, Sept. 6, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company"), is pleased to announce its latest binding term sheet to acquire Roots Rx, a cannabis operator with six dispensaries located in the ski and mountain towns of Colorado. The Company will also acquire Roots Rx's outdoor cultivation facilities located outside of Aspen.
Cannabis company Medicine Man Technologies, Inc. (OTC: MDCL) said Thursday it has signed a binding term sheet to purchase four additional Colorado dispensaries. The newest additions are part of the company’s expansion in the Centennial State. Earlier this week, Medicine Man said it will acquire Colorado Harvest Company an operator of three cannabis dispensaries, and entered a binding term sheet to acquire five Starbuds dispensaries.
- Colorado Harvest Company operates three retail centers in the Denver Metro area and is the Company's ninth proposed acquisition in 2019 - Company will benefit from added retail scale and cross-selling ...
Medicine Man Technologies, Inc. (OTC: MDCL ) said Tuesday it has signed a binding term sheet to purchase five Starbuds dispensaries in Colorado. Per the agreement, the company will acquire five dispensaries ...
- The Company's addition of a group of five dispensaries will increase the retail footprint and regional coverage of the Company in Colorado - As part of the agreement, one of the original industry pioneers, ...
DENVER, Aug. 29, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company") today announced the appointment of Nancy Bush Huber as the Company's Vice President (VP) of Finance.
MedPharm Research, the leader in cannabis research and formulation development, was notified by the Drug Enforcement Administration (DEA) that it had been selected to move forward as one of the first applicants to be granted a license to grow federally legal cannabis under the terms of a new policy statement issued today in the Federal Register. “This is something we have been waiting for since we first sent in our application in September, 2016, as one of the first medical grow facilities to apply for a license,” Albert Gutierrez, CEO of MedPharm, said. “Now, finally, the DEA has seen the importance of allowing federally legal grows to get more active in medical cannabis research, and do the work that we really need to do for patients across the country.
DENVER, Aug. 19, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (MDCL) ("Medicine Man Technologies" or the "Company"), today announced the entry into a binding term sheet to acquire one of Colorado's most well-known edible and extracts companies. Upon completion, the acquisition will expand Medicine Man Technologies' portfolio to now include one of the state's largest manufacturers of a nationwide, reputable lifestyle brand that has an extensive line of cannabis-infused extracts, edibles, and other wellness products. The acquisition is expected to close by the first half of 2020.